Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kunihiko Kobayashi
Institutions:
Saitama International Medical Center,
Saitama Medical University
Observed institutions:
Saitama International Medical Center,
Saitama Medical University
ORCID:
0000-0002-6468-9068
Observed ORCID:
0000-0002-6468-9068
OpenAlex ID:
A5137552690
Patient-Reported Outcomes in FLAURA2: Osimertinib with or without Chemotherapy in Patients with Previously Untreated EGFR-Mutated Advanced Non–Small Cell Lung Cancer
2026
·
Jhanelle E. Gray
, Konstantin Laktionov
, et al.
·
Clinical Cancer Research
·
4
PDF
Long-term safety of first-line osimertinib plus platinum–pemetrexed in EGFR-mutated advanced NSCLC: FLAURA2
2026
·
David Planchard
, Pasi A. Jänne
, et al.
·
Lung Cancer
Data from Patient-Reported Outcomes in FLAURA2: Osimertinib with or without Chemotherapy in Patients with Previously Untreated EGFR-Mutated Advanced Non–Small Cell Lung Cancer
2026
·
Jhanelle E. Gray
, Konstantin Laktionov
, et al.
Supplementary Data from Patient-Reported Outcomes in FLAURA2: Osimertinib with or without Chemotherapy in Patients with Previously Untreated EGFR-Mutated Advanced Non–Small Cell Lung Cancer
2026
·
Jhanelle E. Gray
, Konstantin Laktionov
, et al.
Show more works
View as search
Works count:
4
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type